Cargando…
Abscess formation mimicking disease progression, in a patient with metastatic renal cell carcinoma during sunitinib treatment
BACKGROUND: Renal cell carcinoma (RCC) represents approximately 3% of all adult cancers and is more common in males. Systemic treatment for RCC has improved following the introduction of tyrosine kinase inhibitors, such as sunitinib. The molecular targets of sunitinib are receptor tyrosine kinases (...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890518/ https://www.ncbi.nlm.nih.gov/pubmed/20507643 http://dx.doi.org/10.1186/1477-7819-8-45 |